MediWound files for $80 million Wall Street IPO
Shares of parent company Clal Biotech close 5.2% higher on plan.
Joining the parade of Israeli biotech companies marching toward Wall Street, MediWound has filed a draft prospectus with the U.S. Securities and Exchange Commission for an $80 million initial public offering.
register with haaretz
Like us on Facebook and get articles directly in your news feed